Bupa UK Insurance Agrees New Three-year Contract with Circle Health Group, Owner of BMI
Bupa UK Insurance, the leading private healthcare insurance provider and Circle Health Group, Britain’s largest network of private hospitals, are pleased to announce that they will continue to work together to deliver care to customers with a new three-year contract through to January 2024.
This new contract offers customers a quality healthcare experience at Circle and BMI-branded facilities during this period and will deliver long-term value through sustainable pricing.
The agreement reflects the strong working relationship between Circle and Bupa, with the partners agreeing upon a number of areas to explore the development, innovation and improvement of services for customers.
This includes enhancing the customer journey through streamlined consultant booking processes, rolling out key Bupa specialist care centres for oncology, and exploring pathway management for MSK, cardiology and skin cancer.
Circle owns over 50 hospitals in the UK and offers over 500 different treatments across more than 60 specialities, with centres of excellence in spinal, orthopaedic, neurological, cardiac and cancer care. Circle’s facilities provide wide geographic coverage across the UK, including a wide footprint in Scotland.
Circle is committed to a faster, digital-first booking experience through deep integration with Bupa systems and to innovation by creating new digital technologies and experiences to help patients.
Alex Perry, CEO, Bupa UK Insurance said: “We’re delighted to extend our contract with Circle. Our priority is ensuring our customers have convenient access to quality, affordable healthcare services and that they have a great experience when using their health insurance. This new chapter in Circle and Bupa’s relationship will help further these priorities and is a great example of insurer and hospital provider working together to deliver the best for our customers.”
Paolo Pieri, CEO of Circle Health Group said: “We are proud to be extending our valued partnership with Bupa. After our recent purchase of BMI Healthcare, we’re committed to becoming the most technology-enabled healthcare provider in the country. This year alone we are investing £100m in the latest equipment, technology and infrastructure and to ensure we continue to give patients the best possible hospital experience, with the highest quality and best technology at the core of our offerings.”
People In This Post
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more